Novo Nordisk Foundation allocate DKK 20 million for research into preparedness for and response to new viral infections
11 March 2020
Other news from Denmark
18 November 2019
LEGO Foundation, Reekimlane Foundation and White Rose University Consortium join the EFC
02 August 2019
Villum Fonden launch new grants programme for interdisciplinary data-driven research
Other events in Denmark
02 - 03 April 2020
POSTPONED - EFC European Foundation Financial and Investment Officers Group Spring Meeting 2020
Other good-practices from Denmark
Other blogs from Denmark
16 March 2020
19 February 2020
Virtually everyone’s a winner - Nordea-fonden sets up electronic board meetings
Other Global Challenges, Peace-building Resources
04 December 2020
Innovation in Africa-Europe Relations beyond COVID-19
10 December 2020
Webinar - "Global health philanthropy: is it too much or not enough?"
Other Health and Well-being Resources
01 December 2020
Dr Tedros Adhanom Ghebreyesus, Ban Ki-moon and Wellcome Trust headline new issue of Alliance magazine on global health philanthropy
26 November 2020
A warm EFC welcome to our newest member and affiliates!
Other Research, Science and Technology Resources
24 November 2020
Building a common framework for assessing, understanding and maximizing impact - Insights from the first Virtual Summit on Impact
03 November 2020
Bertelsmann Stiftung and AlgorithmWatch publish mapping exploring the deployment of Automated Decision-Making (ADM) and AI-based systems throughout Europe
The Novo Nordisk Foundation has allocated DKK 20 million to support research and development that can help Denmark to strengthen its preparedness for and response to future new viral epidemics.
The initiative comes in the wake of the ongoing spread of coronavirus (2019-nCoV) as a means to prepare for future events. The grants for interdisciplinary research and development cover projects that provide surveillance and early detection of viral infections, the development of new technologies for preventing or controlling epidemics and the optimisation of national responses to new viral diseases, including policy, procedure, treatment, and technology.